Exclusion Criteria for Participants:~1. No caregiver available to meet the inclusion criteria for
caregivers.~2. Participants with any active or clinically-significant conditions affecting absorption,
distribution, or metabolism of the study medication (example, inflammatory bowel disease, gastric or duodenal
ulcers, hepatic disease, or severe lactose intolerance).~3. Known plan for elective surgery during the study
period that would require general anesthesia and administration of neuromuscular blocking agents, such as
succinylcholine, to induce paralysis/muscle relaxation. Minor surgery, such as colonoscopy or cataract surgery,
will be permitted as long as it does not require the use of these paralytic agents.~4. Participants who are
unwilling or unable to fulfill the requirements of the study.~5. Use of any prohibited prior or concomitant
medications.~6. Any condition that would make the participant, in the opinion of the investigator, unsuitable
for the study.~7. Participant taking concomitant antidepressant medication known to have significant
anticholinergic effects, such as tricyclic antidepressants prescribed at doses recommended for the treatment of
major depression.~8. Participants who cannot swallow or who have difficulty swallowing whole tablets.~9.
Participants taking any alternative medication such as vitamins and/or herbal products or alternative medical
techniques such as acupuncture or acupressure specifically for the treatment of Alzheimer's disease.~Exclusion
Criteria for Caregivers.~1. Caregivers who are unwilling or unable to give informed consent or otherwise to
fulfill the requirements of the study.~2. Any condition that would make the caregiver, in the opinion of the
investigator, unsuitable for the study.
